Lv22
120 积分 2024-10-22 加入
Macrophages in intestinal homeostasis and inflammatory bowel disease
2小时前
待确认
IBD disease-modifying therapies: insights from emerging therapeutics
2小时前
已完结
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
9天前
已完结
Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn’s Disease (EXPLORER)
9天前
已完结
Strategies for targeting cytokines in inflammatory bowel disease
14天前
已完结
Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives
15天前
已完结
TL1A inhibition for inflammatory bowel disease treatment: From inflammation to fibrosis
15天前
已完结
皖公网安备34019202002308
